Li L, Wang H, Zhou Z, Luo J, Wang X, Xiao X, et al. C3-Luc Cells Are an Excellent Model for Evaluation of Cellular Immunity following HPV16L1 Vaccination. PLoS ONE. 2016;11:e0149748 pubmed 出版商

Lamprecht R, Kennedy P, Huddy S, Bethke S, Hendrikse M, Hitzeroth I, et al. Production of Human papillomavirus pseudovirions in plants and their use in pseudovirion-based neutralisation assays in mammalian cells. Sci Rep. 2016;6:20431 pubmed 出版商

Warren C, Griffin L, Little A, Huang I, Farzan M, Pyeon D. The antiviral restriction factors IFITM1, 2 and 3 do not inhibit infection of human papillomavirus, cytomegalovirus and adenovirus. PLoS ONE. 2014;9:e96579 pubmed 出版商

Mboumba Bouassa R, Pere H, Gubavu C, Prazuck T, Jenabian M, Veyer D, et al. Serum and cervicovaginal IgG immune responses against α7 and α9 HPV in non-vaccinated women at risk for cervical cancer: Implication for catch-up prophylactic HPV vaccination. PLoS ONE. 2020;15:e0233084 pubmed 出版商

Schäfer G, Graham L, Lang D, Blumenthal M, Bergant MaruÅ¡ič M, Katz A. Vimentin Modulates Infectious Internalization of Human Papillomavirus 16 Pseudovirions. J Virol. 2017;91: pubmed 出版商

Day P, Thompson C, Lowy D, Schiller J. Interferon Gamma Prevents Infectious Entry of Human Papillomavirus 16 via an L2-Dependent Mechanism. J Virol. 2017;91: pubmed 出版商

Krishnappa P, Mohamad I, Lin Y, Barua A. Expression of P16 in high-risk human papillomavirus related lesions of the uterine cervix in a government hospital, Malaysia. Diagn Pathol. 2014;9:202 pubmed 出版商

Huang H, Lambert P. Use of an in vivo animal model for assessing the role of integrin ?(6)?(4) and syndecan-1 in early steps in papillomavirus infection. Virology. 2012;433:395-400 pubmed 出版商

Day P, Pang Y, Kines R, Thompson C, Lowy D, Schiller J. A human papillomavirus (HPV) in vitro neutralization assay that recapitulates the in vitro process of infection provides a sensitive measure of HPV L2 infection-inhibiting antibodies. Clin Vaccine Immunol. 2012;19:1075-82 pubmed 出版商

Millán A, Gomez Sebastian S, Núñez M, Veramendi J, Escribano J. Human papillomavirus-like particles vaccine efficiently produced in a non-fermentative system based on insect larva. Protein Expr Purif. 2010;74:1-8 pubmed 出版商

Johnson K, Kines R, Roberts J, Lowy D, Schiller J, Day P. Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus. J Virol. 2009;83:2067-74 pubmed 出版商

Fernández San Millán A, Ortigosa S, Hervas Stubbs S, Corral Martínez P, Segui Simarro J, Gaétan J, et al. Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic. Plant Biotechnol J. 2008;6:427-41 pubmed 出版商

Day P, Gambhira R, Roden R, Lowy D, Schiller J. Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies. J Virol. 2008;82:4638-46 pubmed 出版商

Steele J, Mann C, Rookes S, Rollason T, Murphy D, Freeth M, et al. T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia. Br J Cancer. 2005;93:248-59 pubmed